X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs CIPLA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD CIPLA MERCK LTD/
CIPLA
 
P/E (TTM) x 38.7 38.9 99.4% View Chart
P/BV x 5.1 3.3 152.4% View Chart
Dividend Yield % 0.6 0.4 144.6%  

Financials

 MERCK LTD   CIPLA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
CIPLA
Mar-17
MERCK LTD/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,060622 170.4%   
Low Rs623458 135.9%   
Sales per share (Unadj.) Rs632.4181.9 347.8%  
Earnings per share (Unadj.) Rs45.712.9 355.2%  
Cash flow per share (Unadj.) Rs62.329.3 212.6%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.4 353.0%  
Book value per share (Unadj.) Rs388.8155.7 249.7%  
Shares outstanding (eoy) m16.60804.51 2.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.33.0 44.8%   
Avg P/E ratio x18.442.0 43.9%  
P/CF ratio (eoy) x13.518.4 73.3%  
Price / Book Value ratio x2.23.5 62.4%  
Dividend payout %24.115.5 154.8%   
Avg Mkt Cap Rs m13,969434,516 3.2%   
No. of employees `0001.623.0 6.9%   
Total wages/salary Rs m1,48726,338 5.6%   
Avg. sales/employee Rs Th6,631.96,349.1 104.5%   
Avg. wages/employee Rs Th939.21,143.0 82.2%   
Avg. net profit/employee Rs Th479.4449.3 106.7%   
INCOME DATA
Net Sales Rs m10,498146,302 7.2%  
Other income Rs m2422,287 10.6%   
Total revenues Rs m10,741148,589 7.2%   
Gross profit Rs m1,13524,758 4.6%  
Depreciation Rs m27613,229 2.1%   
Interest Rs m01,594 0.0%   
Profit before tax Rs m1,10212,222 9.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,798 19.1%   
Profit after tax Rs m75910,354 7.3%  
Gross profit margin %10.816.9 63.9%  
Effective tax rate %31.114.7 211.8%   
Net profit margin %7.27.1 102.1%  
BALANCE SHEET DATA
Current assets Rs m6,41087,370 7.3%   
Current liabilities Rs m8,82833,081 26.7%   
Net working cap to sales %-23.037.1 -62.1%  
Current ratio x0.72.6 27.5%  
Inventory Days Days5887 66.3%  
Debtors Days Days3862 61.6%  
Net fixed assets Rs m1,406111,567 1.3%   
Share capital Rs m1661,609 10.3%   
"Free" reserves Rs m6,286123,645 5.1%   
Net worth Rs m6,455125,254 5.2%   
Long term debt Rs m036,454 0.0%   
Total assets Rs m8,828209,532 4.2%  
Interest coverage xNM8.7-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.7 170.3%   
Return on assets %8.65.7 150.8%  
Return on equity %11.88.3 142.2%  
Return on capital %17.18.5 200.9%  
Exports to sales %8.334.2 24.2%   
Imports to sales %21.08.3 252.3%   
Exports (fob) Rs m86950,050 1.7%   
Imports (cif) Rs m2,20912,203 18.1%   
Fx inflow Rs m95951,066 1.9%   
Fx outflow Rs m2,61217,678 14.8%   
Net fx Rs m-1,65333,388 -5.0%   
CASH FLOW
From Operations Rs m1,07023,824 4.5%  
From Investments Rs m-750-13,127 5.7%  
From Financial Activity Rs m-150-13,239 1.1%  
Net Cashflow Rs m171-2,478 -6.9%  

Share Holding

Indian Promoters % 0.0 16.0 -  
Foreign collaborators % 51.8 20.8 249.0%  
Indian inst/Mut Fund % 18.2 12.2 149.2%  
FIIs % 1.0 23.7 4.2%  
ADR/GDR % 0.0 1.1 -  
Free float % 29.1 26.2 111.1%  
Shareholders   28,591 161,166 17.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


May 21, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS